256 related articles for article (PubMed ID: 19586417)
1. BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus.
Santi I; Maione D; Galeotti CL; Grandi G; Telford JL; Soriani M
J Infect Dis; 2009 Aug; 200(4):564-70. PubMed ID: 19586417
[TBL] [Abstract][Full Text] [Related]
2. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.
Santi I; Scarselli M; Mariani M; Pezzicoli A; Masignani V; Taddei A; Grandi G; Telford JL; Soriani M
Mol Microbiol; 2007 Feb; 63(3):754-67. PubMed ID: 17212592
[TBL] [Abstract][Full Text] [Related]
3. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.
Meinke AL; Senn BM; Visram Z; Henics TZ; Minh DB; Schüler W; Neubauer C; Gelbmann D; Noiges B; Sinzinger J; Hanner M; Dewasthaly S; Lundberg U; Hordnes K; Masoud H; Sevelda P; von Gabain A; Nagy E
Vaccine; 2010 Oct; 28(43):6997-7008. PubMed ID: 20732466
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
Rainard P; Sarradin P; Poutrel B
Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies targeting different cell wall antigens of group B streptococcus mediate protection in both Fc-dependent and independent manner.
Senn BM; Visram Z; Meinke AL; Neubauer C; Gelbmann D; Sinzinger J; Hanner M; Lundberg U; Boisvert H; Reinscheid D; von Gabain A; Nagy E
Vaccine; 2011 May; 29(24):4116-24. PubMed ID: 21496467
[TBL] [Abstract][Full Text] [Related]
6. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
[TBL] [Abstract][Full Text] [Related]
7. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
[TBL] [Abstract][Full Text] [Related]
8. Identification of a universal Group B streptococcus vaccine by multiple genome screen.
Maione D; Margarit I; Rinaudo CD; Masignani V; Mora M; Scarselli M; Tettelin H; Brettoni C; Iacobini ET; Rosini R; D'Agostino N; Miorin L; Buccato S; Mariani M; Galli G; Nogarotto R; Nardi-Dei V; Vegni F; Fraser C; Mancuso G; Teti G; Madoff LC; Paoletti LC; Rappuoli R; Kasper DL; Telford JL; Grandi G
Science; 2005 Jul; 309(5731):148-50. PubMed ID: 15994562
[TBL] [Abstract][Full Text] [Related]
9. The putative glycosyltransferase-encoding gene cylJ and the group B Streptococcus (GBS)-specific gene cylK modulate hemolysin production and virulence of GBS.
Forquin MP; Tazi A; Rosa-Fraile M; Poyart C; Trieu-Cuot P; Dramsi S
Infect Immun; 2007 Apr; 75(4):2063-6. PubMed ID: 17283108
[TBL] [Abstract][Full Text] [Related]
10. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
[TBL] [Abstract][Full Text] [Related]
11. Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization.
Dos Santos NFB; da Silva LR; Costa FJMD; de Mattos DM; de Carvalho E; Ferreira LCS; Ferreira RCC
Vaccine; 2020 Jul; 38(33):5286-5296. PubMed ID: 32571719
[TBL] [Abstract][Full Text] [Related]
12. Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease.
Buccato S; Maione D; Rinaudo CD; Volpini G; Taddei AR; Rosini R; Telford JL; Grandi G; Margarit I
J Infect Dis; 2006 Aug; 194(3):331-40. PubMed ID: 16826481
[TBL] [Abstract][Full Text] [Related]
13. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study.
Lin FY; Philips JB; Azimi PH; Weisman LE; Clark P; Rhoads GG; Regan J; Concepcion NF; Frasch CE; Troendle J; Brenner RA; Gray BM; Bhushan R; Fitzgerald G; Moyer P; Clemens JD
J Infect Dis; 2001 Oct; 184(8):1022-8. PubMed ID: 11574917
[TBL] [Abstract][Full Text] [Related]
14. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
Cauchard J; Sevin C; Ballet JJ; Taouji S
Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.
Seepersaud R; Hanniffy SB; Mayne P; Sizer P; Le Page R; Wells JM
Infect Immun; 2005 Mar; 73(3):1671-83. PubMed ID: 15731068
[TBL] [Abstract][Full Text] [Related]
16. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm.
Margarit I; Rinaudo CD; Galeotti CL; Maione D; Ghezzo C; Buttazzoni E; Rosini R; Runci Y; Mora M; Buccato S; Pagani M; Tresoldi E; Berardi A; Creti R; Baker CJ; Telford JL; Grandi G
J Infect Dis; 2009 Jan; 199(1):108-15. PubMed ID: 19086816
[TBL] [Abstract][Full Text] [Related]
17. Identification of immunoreactive extracellular proteins of Streptococcus agalactiae in bovine mastitis.
Trigo G; Ferreira P; Ribeiro N; Dinis M; Andrade EB; Melo-Cristino J; Ramirez M; Tavares D
Can J Microbiol; 2008 Nov; 54(11):899-905. PubMed ID: 18997846
[TBL] [Abstract][Full Text] [Related]
18. The streptococcal Blr and Slr proteins define a family of surface proteins with leucine-rich repeats: camouflaging by other surface structures.
Waldemarsson J; Areschoug T; Lindahl G; Johnsson E
J Bacteriol; 2006 Jan; 188(2):378-88. PubMed ID: 16385027
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae.
Rosini R; Rinaudo CD; Soriani M; Lauer P; Mora M; Maione D; Taddei A; Santi I; Ghezzo C; Brettoni C; Buccato S; Margarit I; Grandi G; Telford JL
Mol Microbiol; 2006 Jul; 61(1):126-41. PubMed ID: 16824100
[TBL] [Abstract][Full Text] [Related]
20. Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.
Larsson C; Lindroth M; Nordin P; Stålhammar-Carlemalm M; Lindahl G; Krantz I
Arch Dis Child Fetal Neonatal Ed; 2006 Nov; 91(6):F403-8. PubMed ID: 17056838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
